Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

September 13, 2022; 99 (11) Research Articles

β-Amyloid and Tau Imaging in Chronic Traumatic Brain Injury

A Cross-sectional Study

View ORCID ProfileAmelia J. Hicks, View ORCID ProfileJennie L. Ponsford, View ORCID ProfileGershon Spitz, View ORCID ProfileVincent Dore, View ORCID ProfileNatasha Krishnadas, Caroline Roberts, View ORCID ProfileChristopher C. Rowe
First published June 15, 2022, DOI: https://doi.org/10.1212/WNL.0000000000200857
Amelia J. Hicks
From the Monash-Epworth Rehabilitation Research Centre (A.H., J.L.P., G.S., C.R.), Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton; Department of Molecular Imaging and Therapy (V.D., N.K., C.C.R.), Austin Health, Heidelberg; Florey Department of Neuroscience and Mental Health (N.K., C.C.R.), University of Melbourne; and CSIRO Health and Biosecurity Flagship (V.D.), The Australian e-Health Research Centre, Parkville, Australia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Amelia J. Hicks
Jennie L. Ponsford
From the Monash-Epworth Rehabilitation Research Centre (A.H., J.L.P., G.S., C.R.), Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton; Department of Molecular Imaging and Therapy (V.D., N.K., C.C.R.), Austin Health, Heidelberg; Florey Department of Neuroscience and Mental Health (N.K., C.C.R.), University of Melbourne; and CSIRO Health and Biosecurity Flagship (V.D.), The Australian e-Health Research Centre, Parkville, Australia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jennie L. Ponsford
Gershon Spitz
From the Monash-Epworth Rehabilitation Research Centre (A.H., J.L.P., G.S., C.R.), Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton; Department of Molecular Imaging and Therapy (V.D., N.K., C.C.R.), Austin Health, Heidelberg; Florey Department of Neuroscience and Mental Health (N.K., C.C.R.), University of Melbourne; and CSIRO Health and Biosecurity Flagship (V.D.), The Australian e-Health Research Centre, Parkville, Australia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gershon Spitz
Vincent Dore
From the Monash-Epworth Rehabilitation Research Centre (A.H., J.L.P., G.S., C.R.), Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton; Department of Molecular Imaging and Therapy (V.D., N.K., C.C.R.), Austin Health, Heidelberg; Florey Department of Neuroscience and Mental Health (N.K., C.C.R.), University of Melbourne; and CSIRO Health and Biosecurity Flagship (V.D.), The Australian e-Health Research Centre, Parkville, Australia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vincent Dore
Natasha Krishnadas
From the Monash-Epworth Rehabilitation Research Centre (A.H., J.L.P., G.S., C.R.), Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton; Department of Molecular Imaging and Therapy (V.D., N.K., C.C.R.), Austin Health, Heidelberg; Florey Department of Neuroscience and Mental Health (N.K., C.C.R.), University of Melbourne; and CSIRO Health and Biosecurity Flagship (V.D.), The Australian e-Health Research Centre, Parkville, Australia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Natasha Krishnadas
Caroline Roberts
From the Monash-Epworth Rehabilitation Research Centre (A.H., J.L.P., G.S., C.R.), Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton; Department of Molecular Imaging and Therapy (V.D., N.K., C.C.R.), Austin Health, Heidelberg; Florey Department of Neuroscience and Mental Health (N.K., C.C.R.), University of Melbourne; and CSIRO Health and Biosecurity Flagship (V.D.), The Australian e-Health Research Centre, Parkville, Australia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher C. Rowe
From the Monash-Epworth Rehabilitation Research Centre (A.H., J.L.P., G.S., C.R.), Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton; Department of Molecular Imaging and Therapy (V.D., N.K., C.C.R.), Austin Health, Heidelberg; Florey Department of Neuroscience and Mental Health (N.K., C.C.R.), University of Melbourne; and CSIRO Health and Biosecurity Flagship (V.D.), The Australian e-Health Research Centre, Parkville, Australia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christopher C. Rowe
Full PDF
Short Form
Citation
β-Amyloid and Tau Imaging in Chronic Traumatic Brain Injury
A Cross-sectional Study
Amelia J. Hicks, Jennie L. Ponsford, Gershon Spitz, Vincent Dore, Natasha Krishnadas, Caroline Roberts, Christopher C. Rowe
Neurology Sep 2022, 99 (11) e1131-e1141; DOI: 10.1212/WNL.0000000000200857

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
153

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Abstract

Background and Objectives Traumatic brain injury (TBI) has been promoted as a risk factor for Alzheimer disease (AD). There is evidence of elevated β-amyloid (Aβ) and tau, the pathologic hallmarks of AD, immediately following TBI. It is not clear whether Aβ and tau remain elevated in the chronic period. To address this issue, we assessed Aβ and tau burden in long-term TBI survivors and healthy controls using PET imaging.

Methods Using a cross-sectional design, we recruited individuals following a single moderate to severe TBI at least 10 years previously from an inpatient rehabilitation program. A demographically similar healthy control group was recruited from the community. PET data were acquired using 18F-NAV4694 (Aβ) and 18F-MK6240 (tau) tracers. Aβ deposition was quantified using the Centiloid scale. Tau deposition was quantified using the standardized uptake value ratio (SUVR) in 4 regions of interest (ROIs). As a secondary measure, PET scans were also visually read as positive or negative. We examined PET data in relation to time since injury and age at injury. PET data were analyzed in a series of regression analyses.

Results The sample comprised 87 individuals with TBI (71.3% male; 28.7% female; mean 57.53 years, SD 11.53) and 59 controls (59.3% male; 40.7% female; mean 60.34 years, SD 11.97). Individuals with TBI did not have significantly higher 18F-NAV4694 Centiloid values (p = 0.067) or 18F-MK6240 tau SUVRs in any ROI (p ≤ 0.001; SUVR greater for controls). Visual assessment was consistent with the quantification; individuals with TBI were not more likely than controls to have a positive Aβ (p = 0.505) or tau scan (p = 0.221). No associations were identified for Aβ or tau burden with time since injury (p = 0.057 to 0.332) or age at injury.

Discussion A single moderate to severe TBI was not associated with higher burden of Aβ or tau pathologies in the chronic period relative to healthy controls. Aβ and tau burden did not show a significant increase with years since injury, and burden did not appear to be greater for those who were older at the time of injury.

Glossary

Aβ=
β-amyloid;
AD=
Alzheimer disease;
CapAIBL=
Computational Analysis of PET from AIBL;
Me=
mesial temporal;
OR=
odds ratio;
PTA=
posttraumatic amnesia;
ROI=
region of interest;
SUVR=
standardized uptake value ratio;
TBI=
traumatic brain injury;
Te=
temporoparietal

Footnotes

  • Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

  • This Null Hypothesis article is published as part of a collaborative effort between Neurology and CBMRT.

  • Submitted and externally peer reviewed. The handling editor was Rebecca Burch, MD.

  • Null Hypothesis: NPub.org/Null

  • Received December 2, 2021.
  • Accepted in final form May 2, 2022.
  • © 2022 American Academy of Neurology
View Full Text

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Glossary
    • Methods
    • Results
    • Discussion
    • Study Funding
    • Disclosure
    • Acknowledgment
    • Appendix Authors
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study

Dr. Robert Shapiro and Dr. Amynah Pradhan

► Watch

Related Articles

  • Spotlight on the September 13 Issue

Topics Discussed

  • Alzheimer's disease
  • Brain trauma
  • PET

Alert Me

  • Alert me when eletters are published
Neurology: 100 (5)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise